Natalie Clare Silmon De Monerri

Title: The Innovations of Natalie Clare Silmon De Monerri

Introduction

Natalie Clare Silmon De Monerri is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of biotechnology, particularly in the design of mutated FimH polypeptides. Her work focuses on improving biochemical properties and immunogenicity, which has important implications for medical research and treatment.

Latest Patents

Natalie holds 1 patent for her invention titled "FimH mutants and uses thereof." This patent discloses the design of mutated FimH polypeptides that enhance biochemical properties and immunogenicity. The compositions comprising these polypeptides and their various uses are crucial for advancing therapeutic applications.

Career Highlights

Natalie is currently employed at Pfizer Corporation, a leading global pharmaceutical company. Her role involves extensive research and development in the field of immunology and biochemistry. Her innovative approach has positioned her as a key figure in her area of expertise.

Collaborations

Throughout her career, Natalie has collaborated with notable colleagues, including Ye Che and Laurent Oliver Chorro. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Natalie Clare Silmon De Monerri exemplifies the spirit of innovation in biotechnology. Her contributions, particularly in the development of FimH mutants, highlight the importance of research in improving health outcomes. Her work continues to inspire future advancements in the field.